Impact of substandard and falsified antimalarials in Zambia: application of the SAFARI model
Abstract Background Many countries are striving to become malaria-free, but global reduction in case estimates has stagnated in recent years. Substandard and falsified medicines may contribute to this lack of progress. Zambia aims to eliminate their annual burden of 1.2 million pediatric malaria cas...
Main Authors: | Kathryn D. Jackson, Colleen R. Higgins, Sarah K. Laing, Chiluba Mwila, Tamaki Kobayashi, Matthew M. Ippolito, Sean Sylvia, Sachiko Ozawa |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-07-01
|
Series: | BMC Public Health |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12889-020-08852-w |
Similar Items
-
Development of an agent-based model to assess the impact of substandard and falsified anti-malarials: Uganda case study
by: Sachiko Ozawa, et al.
Published: (2019-01-01) -
Substandard and Falsified Medicines in Myanmar
by: Mirai Sakuda, et al.
Published: (2020-03-01) -
Substandard and falsified medicine screening technologies
by: Lukas Roth, et al.
Published: (2019-07-01) -
Global scenario of counterfeit antimalarials: A potential threat
by: Taruna Arora, et al.
Published: (2019-01-01) -
A cross-sectional analysis of falsified, counterfeit and substandard medicines in a low-middle income country
by: Daariimaa Khurelbat, et al.
Published: (2020-05-01)